This guide provides practical, evidence-based information that first responder agencies, their partners, and communities can use to implement or expand practices and programs for linking people to substance use services.
Dashboard: Filter Bricks
Main page content
This model standards guidance document, SAMHSA's National Model Standards for Peer Support Certification, is prepared in response to President Biden's 2022 Unity Agenda. This document outlines model standards for substance use disorder, mental health, and family/youth peer support certification.
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
This manual guides clinicians through stages of primary care for alcohol and substance misuse in adult patients. It discusses warning signs of misuse, screening and follow-up, brief intervention, assessment, treatment models, and legal issues. It includes four screening tools.
This manual offers guidance to clinicians on implementing drug testing in their practice. It presents the mechanics of testing and outlines steps for preparing staff.
This manual offers guidance and tools for identifying mental illness or substance use issues early in children and adolescents in various setting, such as in schools, the juvenile justice and child welfare system, and when receiving primary care.
This guide provides clinicians with questions to begin discussions with adult patients about mental illness, substance use disorders, or both. It includes resources for patients who need an evaluation after a positive screening.
This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.